115 related articles for article (PubMed ID: 27539118)
1. Allosteric Modulation of Phosphatase Activity May Redefine Therapeutic Value.
Salamoun JM; Wipf P
J Med Chem; 2016 Sep; 59(17):7771-2. PubMed ID: 27539118
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities in the development of protein phosphatase-directed therapeutics.
De Munter S; Köhn M; Bollen M
ACS Chem Biol; 2013 Jan; 8(1):36-45. PubMed ID: 23214403
[TBL] [Abstract][Full Text] [Related]
3. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Stanford SM; Bottini N
Nat Rev Drug Discov; 2023 Apr; 22(4):273-294. PubMed ID: 36693907
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein serine/threonine phosphatases for drug development.
McConnell JL; Wadzinski BE
Mol Pharmacol; 2009 Jun; 75(6):1249-61. PubMed ID: 19299564
[TBL] [Abstract][Full Text] [Related]
5. Two-track virtual screening approach to identify both competitive and allosteric inhibitors of human small C-terminal domain phosphatase 1.
Park H; Lee HS; Ku B; Lee SR; Kim SJ
J Comput Aided Mol Des; 2017 Aug; 31(8):743-753. PubMed ID: 28653253
[TBL] [Abstract][Full Text] [Related]
6. Chemical probe development versus drug development.
Jackson MR
Methods Mol Biol; 2013; 1053():1-6. PubMed ID: 23860644
[TBL] [Abstract][Full Text] [Related]
7. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
Verkhivker GM
Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulators of MEK1: drug design and discovery.
Shang J; Lu S; Jiang Y; Zhang J
Chem Biol Drug Des; 2016 Oct; 88(4):485-97. PubMed ID: 27115708
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
Lütjens R; Rocher JP
Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of caspases.
Häcker HG; Sisay MT; Gütschow M
Pharmacol Ther; 2011 Nov; 132(2):180-95. PubMed ID: 21807025
[TBL] [Abstract][Full Text] [Related]
11. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.
Ducruet AP; Vogt A; Wipf P; Lazo JS
Annu Rev Pharmacol Toxicol; 2005; 45():725-50. PubMed ID: 15822194
[TBL] [Abstract][Full Text] [Related]
12. Phosphoprotein phosphatases.
Li HC
Curr Top Cell Regul; 1982; 21():129-74. PubMed ID: 6183053
[No Abstract] [Full Text] [Related]
13. Phosphatases as targets for cancer treatment.
Lazo JS; Wipf P
Curr Opin Investig Drugs; 2009 Dec; 10(12):1297-304. PubMed ID: 19943201
[TBL] [Abstract][Full Text] [Related]
14. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase regulation by endogenous inhibitors.
Shenolikar S
Semin Cancer Biol; 1995 Aug; 6(4):219-27. PubMed ID: 8541517
[TBL] [Abstract][Full Text] [Related]
17. Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors.
Zhang L; Qiu B; Xiong B; Li X; Li J; Wang X; Li J; Shen J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2118-22. PubMed ID: 17303416
[TBL] [Abstract][Full Text] [Related]
18. Allosteric targeting of receptor tyrosine kinases.
De Smet F; Christopoulos A; Carmeliet P
Nat Biotechnol; 2014 Nov; 32(11):1113-20. PubMed ID: 25380447
[TBL] [Abstract][Full Text] [Related]
19. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of phosphatase inhibitors.
Vintonyak VV; Antonchick AP; Rauh D; Waldmann H
Curr Opin Chem Biol; 2009 Jun; 13(3):272-83. PubMed ID: 19410499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
